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Abstract 
 
Rodent (mouse and rat) models have been crucial in developing our understanding 
of human neurogenesis and neural stem cell (NSC) biology. The study of 
neurogenesis in rodents has allowed us to begin to understand adult human 
neurogenesis and in particular, protocols established for isolation and in vitro 
propagation of rodent NSCs have successfully been applied to the expansion of 
human NSCs. Furthermore, rodent models have played a central role in studying 
NSC function in vivo and in the development of NSC transplantation strategies for 
cell therapy applications. Rodents and humans share many similarities in the 
process of neurogenesis and NSC biology however distinct species differences are 
important considerations for the development of more efficient human NSC 
therapeutic applications. Here we review the important contributions rodent studies 
have had to our understanding of human neurogenesis and to the development of in 
vitro and in vivo NSC research. Species differences will be discussed to identify key 
areas in need of further development for human NSC therapy applications.  
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Introduction 
 
Neural stem cells (NSCs) are multipotent stem cells of the central nervous system 
(CNS) responsible for neurogenesis - the production of functional neurons 
throughout life. NSCs have the ability to self-renew, giving rise to neurons, 
astrocytes and oligodendrocytes through asymmetric division and due to their 
multilineage potential, NSCs hold tremendous potential for the regenerative 
treatment of CNS injuries [1].  Neurogenesis is conserved amongst mammalian 
species with the current understanding of human neurogenesis and NSC biology 
largely reliant upon studies on rodent mouse and rat model organisms. Additionally, 
these models have played a central role in the development of NSC isolation and in 
vitro expansion protocols and in the development of in vivo NSC transplantation 
strategies. In order to advance from rodent studies to successful human therapeutic 
applications, an understanding of the specific differences between rodent and human 
cells is crucial. This review will summarise the importance rodent models have had 
on understanding human neurogenesis, NSC biology and developing NSC 
transplantation methods. An insight into model and species differences will be given 
and future considerations on extrapolating rodent data into humans will be 
discussed.   
 
Adult rodent and human neurogenesis – historical perspective, biological overview 
and species comparison 
 
Adult neurogenesis is a relatively recently accepted occurrence, with neurogenesis 
previously thought to occur only in the developing brain. Our understanding of adult 
neurogenesis began in the 1960s with ground breaking work by Altman & Das, who 
demonstrated the presence of neurogenesis in the postnatal rat brain [2]. This work 
was initially controversial until further work by Kaplan and colleagues in the 1970s 
and 1980s demonstrated that new neurons were indeed produced in the adult rat 
and mouse brain, confirming the findings of Altman and Das [3, 4]. Following this, 
after elaborate research into adult neurogenesis in rodents, a breakthrough in 
understanding human neurogenesis occurred in the late 1990s, when Eriksson and 
colleagues demonstrated the presence of dividing and differentiating cells in the 
adult human brain. Neurogenesis was detected in a 72-year-old subject, 
demonstrating the persistence of neurogenesis throughout life and giving a new 
understanding of nervous system biology [5].  
 
Adult neurogenesis is now commonly accepted and the biology of rodent 
neurogenesis is well understood. In the adult rodent brain two major neurogenic 
areas have been identified: i) the subventricular zone (SVZ) lining the walls of the 
lateral ventricles, and ii) the subgranular zone (SGZ) of the dentate gyrus (DG) in the 
hippocampus; both regions contain NSCs that generate new neurons [6]. NSCs in 
the SVZ and the SGZ give rise to neuroblasts that migrate to their target sites where 
they mature into neurons. SVZ NSCs generate neuroblasts that migrate a long 
distance in chain formation through the rostral migratory stream (RMS) to the 
olfactory bulb (OB) giving rise to OB neurons [7]. Neuroblasts generated from the 
SGZ NSCs migrate only locally maturing into hippocampal dentate granule cell 
neurons [6]. Interestingly, NSCs from both the SVZ and SGZ have been shown to 
resemble astrocytes [8, 9]. 
 
Identification of the neurogenic areas in the rodent brain led to the discovery of 
neurogenic areas in the adult human brain. Following the demonstration of adult 
human hippocampal neurogenesis, comparison of the expression of neurogenesis-
associated markers between the human and rat hippocampus revealed the same 
markers were expressed in the two species [5]. The presence of proliferating cells in 
the adult human SVZ was demonstrated several years later and as in rodents, these 
cells also resembled astrocytes [10]. The adult human RMS was not initially 
identified, requiring further research leading to its characterisation. The human RMS 
differs structurally from the rodent RMS, however as with the rodent, the human 
RMS also contains migrating neuroblasts [11]. Continued investigations have shown 
that, as with the rodent RMS, neuroblasts in the human fetal RMS form chains, 
however, due to the small number of migratory neuroblasts, no evidence of chain 
migration in the adult human RMS has been observed [12]. In addition, to date, there 
is currently no evidence of neuroblasts in the adult human OB, thus the fate of 
human SVZ neuroblasts remains unknown [12]. A summary comparing the 
milestones and advances of adult neurogenesis research in rodent and human 
models is presented in figure 1. 
 
Neurogenesis is conserved amongst mammalian species, supported by similar 
neurogenesis-associated marker expression between rodents and humans. 
Interestingly, the spatial as well as temporal expression of these markers is similar 
between the two models [13]. A common characteristic to both rodent and human 
neurogenesis is the decrease with age, however the relative decrease is higher in 
rodents than humans [13, 14]. Other reported differences between rodent and 
human neurogenesis include hippocampal neuron turnover, i.e. the number of new 
neurons added to the DG to replace missing neurons, which has reported to be 
higher in humans than in rodents [14]. In addition, a distinct and unique attribute of 
the human SVZ is a structure termed the astrocyte ribbon, which has not been 
observed in any other species [10]. In addition, lack of chain migration in the adult 
human RMS demonstrates that human neurogenesis contains unique features that 
differ from the rodent [12]. An overview of differences between adult rodent and 
human neurogenesis is presented in table 1.  
 
Rodent and human neural stem cell models – isolation and in vitro expansion 
 
The understanding that neurogenesis persists in the adult mammalian brain lead to 
the search of common precursor cells of neurons and glial cells in the CNS. This was 
achieved in the early 1990s when neural precursor cells with multilineage 
differentiation capacity were isolated from adult mouse and rat brains [15, 16]. 
Subsequent identification and isolation of human NSCs was achieved in the late 
1990s, a significant breakthrough in human NSC research [17]. The discovery of 
NSCs resulted in the establishment of rodent and human NSC in vitro isolation and 
culturing protocols and today multiple rodent and human NSC lines are routinely 
expanded and commercially available. The culture conditions for the in vitro 
propagation of both rodent and human NSCs are similar, using serum-free 
conditions along with the presence of key growth factors, EGF and FGF-2, to 
maintain cells in an undifferentiated state [18].  
 
The two main methods of expanding NSCs in culture are the neurosphere assay and 
the adherent monolayer culturing system. The neurosphere assay developed by 
Reynolds and Weiss in 1992, was the initial assay established for the isolation and in 
vitro propagation of NSCs from the rodent brain [16]. A neurosphere is a free-floating 
cluster of cells formed by cells composed of NSCs, progenitor cells and 
differentiating cells. During primary neurosphere culture, using serum-free culture 
conditions in the presence of EGF and FGF-2, the majority of the cells die, leaving 
the NSCs, which are responsive to these culture conditions [19]. The primary 
neurosphere can then be dissociated to form secondary spheres, which can be 
further propagated or induced to differentiate toward the neural lineages [19]. The 
formation of secondary spheres and their subsequent differentiation represents the 
self-renewal and multipotent differentiation capacity of NSCs [19]. The neurosphere 
assay is well established and has been successfully applied to the isolation and 
propagation of NSCs from the fetal and adult human brain [17, 20]. 
 
Adherent monolayer culturing of NSCs offers an alternative to the neurosphere 
assay, which is challenged by high cell heterogeneity and the low number of NSCs 
within a neurosphere [21]. In adherent long-term culturing, the presence of both EGF 
and FGF-2 is required to support symmetrical division of NSCs and to maintain their 
multilineage differentiation potential [21]. Protocols for the stable adherent culture of 
rodent and human NSCs are now well established with differentiation of adherent 
NSC cultures achieved through plating of the cells on extracellular matrix substances 
such as laminin [21].  An advantage of these methods includes maintaining high 
levels of homogeneity, reduced spontaneous differentiation and the potential to 
expand the cells to over 40 passages [18]. Adherent NSC cultures can also been 
derived from embryonic stem cells (ESCs) through exposure to defined culture 
conditions to induce neural differentiation [22]. ESCs are pluripotent with a high 
expansive potential and differentiation of NSCs from human ESCs provides an 
advantageous means to derive human NSCs [22]. Advances in NSC isolation and 
the development of in vitro culturing methods are illustrated in figure 1.  
 
Comparison of rodent and human NSCs and their therapeutic potential 
 
Rodent and human NSCs share many common characteristics including the use of 
similar culture conditions for in vitro propagation and the expression of markers used 
for lineage identification and characterisation. Upon withdrawal of growth factors, 
both rodent and human NSCs can be induced to differentiate toward the three neural 
lineages: neurons, astrocytes and oligodendrocytes [18]. The self-renewal and 
multilineage differentiation abilities of both rodent and human NSCs are 
characterised during in vitro expansion through the expression of markers, many of 
which are common between rodents and humans [23]. Commonly utilised NSC 
characterisation markers are summarised in table 2.  
 
Several studies undertaking direct comparisons have reported distinct differences 
between rodent and human NSCs. These include differences in surface marker 
expression including the detection of several surface markers in human cells not 
expressed in rodent cells [24]. Rodent and human NSCs have been shown to 
respond differently in culture to cytokines and growth factors suggesting regulation 
by different signalling environments [25]. In addition, distinct differences in neural 
lineage differentiation and the rate of cell growth have been demonstrated between 
rodent and human NSCs. [26]. Interestingly rodent NSCs have been shown to 
express higher levels of telomerase and exhibit longer telomeres than human NSCs 
[27]. Differences in sensitivity to neurotoxins and chemicals affecting proliferation 
and apoptosis between rodent and human NSCs have also been reported and 
furthermore, human cells show a higher level of variation in neurite outgrowth from 
culture to culture than rodent cells [28, 29]. These observations highlight important 
differences that need to be acknowledged and considered when expanding these 
cells and developing models of repair. 
 
The self-renewal and multilineage differentiation ability of NSCs make them a 
promising cell therapy tool for the regenerative treatment of CNS damage and due to 
the establishment of rodent and human NSC isolation and in vitro expansion 
protocols, our understanding of NSC biology has vastly broadened. Importantly, 
rodent models of neurodegenerative disease and brain injury have contributed to the 
development of transplantation strategies for in vivo applications. NSC 
transplantation experiments initially conducted through rodent-rodent studies, 
successfully demonstrated that isolation, in vitro expansion and subsequent 
transplantation produced viable cells that survived and differentiated in the host [30]. 
These promising results inspired the testing of human NSC transplantation in rodent 
models. Interestingly, despite the acknowledged differences in brain structure, 
human NSCs survived, migrated and differentiated in the host rodent brain [31].  
 
With rodents accepting human cells with a limited immune response upon 
transplantation [32], the use of rodent models have enabled testing of modified, or 
“primed” human NSCs for the development of more efficient human NSC 
transplantation strategies [33]. Ultimately, human NSC research is aimed at the 
development of successful transplantation strategies of human cells into human 
hosts for the treatment of neurodegenerative disease or brain injury. To date, this 
has included the use of cells from several sources including induced pluripotent stem 
cells, mesenchymal stem cells as well as human fetal and adult NSCs (reviewed in 
[34, 35]). However, human NSC therapy remains challenging. The use of fetal 
human cells raises ethical issues and adult cell therapy is challenged with difficulties 
in harvesting cells, limited expansive potential of adult cells as well as developing 
methods for the successful transplantation into human hosts [34]. Thus, the need for 
further development of improved human NSC transplantation strategies remains an 
important area of investigation by researchers and clinicians alike. 
 
Rodent models and human cells - toward developing improved strategies of human 
NSC transplantation 
 
Rodents have played a major role in NSC research and specifically, in the 
application of NSCs for the treatment of CNS damage. The benefit of using rodent 
NSCs include the ease of deriving and establishing in vitro expansion models of 
these cells, enabling the examination of adult NSCs, with adult human NSCs 
challenging to harvest. In addition, rodent models have enabled the study of NSC 
function in vivo and the development of NSC transplantation methods.  As such, 
much of the knowledge obtained from rodents has been successfully applied to 
human NSC studies. However, in order to develop improved human NSC 
transplantation strategies, the clear similarities and differences between the two 
models is an important consideration when extrapolating rodent NSC data into the 
human system. 
  
Studies in rodent models that have been translated to human studies have been 
based on the identified similarities between rodent and human NSCs in terms of their 
expansion and growth characteristics and marker expression within their localised 
microenvironment. However, reported differences including surface markers as well 
responsiveness to signalling molecules suggests rodent and human NSCs are 
regulated through different mechanisms and different signalling events or pathways 
[24, 25]. Reported differences in sensitivity of the two cell populations upon exposure 
to exogenous chemicals [28, 29] highlight distinct species differences and suggest 
direct comparisons of the these models are not always applicable. As an example, 
NSC transplantation experiments of rodent and human NSCs into rodent hosts have 
been successful, with survival, migration and differentiation of transplanted NSCs 
observed [30-33]. However, the central difficulty in applying rodent protocols to 
human cells lies in the acknowledged structural complexity of the human brain and 
associated biological differences in rodent and human neurogenesis. In particular, 
observed in vitro differences between rodent and human NSCs indicate the two cell 
types do not follow the same pattern of growth and migration upon transplantation. 
Furthermore, the significantly larger size of the human brain places an additional 
load in terms of number of transplanted NSCs in order to improve the likelihood of 
success, as they will likely face challenges during migration to the target site. A 
summary of the comparison between rodent and human NSC models, outlining 
similarities and differences is presented in figure 2.  
 
Further comparative studies are required to gain a full and comprehensive 
understanding of the species differences between rodent and human NSCs and their 
therapeutic potential. Rodent models have been central to our current understanding 
of the in vivo molecular and cellular interactions of NSCs, but further study utilising 
human neural tissue is required to understand key aspects of human-specific 
nervous system biology. Through combining our knowledge of human in vitro NSC 
data with rodent in vivo studies, with an understanding of differences between rodent 
and human NSC regulatory factors, these models will provide data more readily 
applicable to human applications.  Our ability to successfully target these similarities 
and differences can be applied to the development of more efficient human NSC 
therapeutic applications to establish strategies for the successful transplantation of 
human NSCs into a human host.  
 
Conclusions 
 
As rodent and human NSCs share similar in vitro culture conditions, protocols 
established for rodent NSCs have successfully been applied to the isolation and 
expansion of human NSCs. The establishment of rodent and human in vitro NSC 
culturing systems has enabled an understanding of NSC biology in vitro and the 
application of this knowledge to in vivo regenerative treatment models of CNS 
injuries. Although progress has been made with human NSC models, this research 
faces a number of challenges. Human NSCs, in particular adult NSCs are difficult to 
harvest and human NSC transplantation remains difficult. The development of 
improved in vitro models of human NSCs for therapeutic applications are needed 
with the use of these cells in combination with rodent models likely to provide insight 
into in vivo regulatory mechanisms. A thorough understanding of both the similarities 
and differences between rodent and human NSC models is required to ensure the 
efficacy of these models. 
 
Acknowledgements 
This review was supported through Queensland University of Technology 
postgraduate research awards (QUTPRA and IPRS) and the Estate of the late Clem 
Jones AO. 
  
References 
 
1. Gage FH. Mammalian neural stem cells. Science (New York, NY). 2000 Feb 
25;287(5457):1433-8. 
2. Altman J, Das GD. Autoradiographic and histological evidence of postnatal 
hippocampal neurogenesis in rats. The Journal of comparative neurology. 1965 
Jun;124(3):319-35. 
3. Kaplan MS, Bell DH. Mitotic neuroblasts in the 9-day-old and 11-month-old 
rodent hippocampus. The Journal of neuroscience : the official journal of the Society 
for Neuroscience. 1984 Jun;4(6):1429-41. 
4. Kaplan MS, Hinds JW. Neurogenesis in the adult rat: electron microscopic 
analysis of light radioautographs. Science (New York, NY). 1977 Sep 
9;197(4308):1092-4. 
5. Eriksson PS, Perfilieva E, Bjork-Eriksson T, Alborn AM, Nordborg C, Peterson 
DA, et al. Neurogenesis in the adult human hippocampus. Nature medicine. 1998 
Nov;4(11):1313-7. 
6. Alvarez-Buylla A, Lim DA. For the long run: maintaining germinal niches in the 
adult brain. Neuron. 2004 Mar 4;41(5):683-6. 
7. Lois C, Garcia-Verdugo JM, Alvarez-Buylla A. Chain migration of neuronal 
precursors. Science (New York, NY). 1996 Feb 16;271(5251):978-81. 
8. Doetsch F, Caille I, Lim DA, Garcia-Verdugo JM, Alvarez-Buylla A. 
Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. 
Cell. 1999 Jun 11;97(6):703-16. 
9. Seri B, Garcia-Verdugo JM, McEwen BS, Alvarez-Buylla A. Astrocytes give 
rise to new neurons in the adult mammalian hippocampus. The Journal of 
neuroscience : the official journal of the Society for Neuroscience. 2001 Sep 
15;21(18):7153-60. 
10. Sanai N, Tramontin AD, Quinones-Hinojosa A, Barbaro NM, Gupta N, Kunwar 
S, et al. Unique astrocyte ribbon in adult human brain contains neural stem cells but 
lacks chain migration. Nature. 2004 Feb 19;427(6976):740-4. 
11. Curtis MA, Kam M, Nannmark U, Anderson MF, Axell MZ, Wikkelso C, et al. 
Human neuroblasts migrate to the olfactory bulb via a lateral ventricular extension. 
Science (New York, NY). 2007 Mar 2;315(5816):1243-9. 
12. Wang C, Liu F, Liu YY, Zhao CH, You Y, Wang L, et al. Identification and 
characterization of neuroblasts in the subventricular zone and rostral migratory 
stream of the adult human brain. Cell research. 2011 Nov;21(11):1534-50. 
13. Knoth R, Singec I, Ditter M, Pantazis G, Capetian P, Meyer RP, et al. Murine 
features of neurogenesis in the human hippocampus across the lifespan from 0 to 
100 years. PloS one. 2010;5(1):e8809. 
14. Spalding KL, Bergmann O, Alkass K, Bernard S, Salehpour M, Huttner HB, et 
al. Dynamics of hippocampal neurogenesis in adult humans. Cell. 2013 Jun 
6;153(6):1219-27. 
15. Palmer TD, Ray J, Gage FH. FGF-2-responsive neuronal progenitors reside 
in proliferative and quiescent regions of the adult rodent brain. Molecular and cellular 
neurosciences. 1995 Oct;6(5):474-86. 
16. Reynolds BA, Weiss S. Generation of neurons and astrocytes from isolated 
cells of the adult mammalian central nervous system. Science (New York, NY). 1992 
Mar 27;255(5052):1707-10. 
17. Kukekov VG, Laywell ED, Suslov O, Davies K, Scheffler B, Thomas LB, et al. 
Multipotent stem/progenitor cells with similar properties arise from two neurogenic 
regions of adult human brain. Experimental neurology. 1999 Apr;156(2):333-44. 
18. Sun Y, Pollard S, Conti L, Toselli M, Biella G, Parkin G, et al. Long-term 
tripotent differentiation capacity of human neural stem (NS) cells in adherent culture. 
Molecular and cellular neurosciences. 2008 Jun;38(2):245-58. 
19. Reynolds BA, Rietze RL. Neural stem cells and neurospheres--re-evaluating 
the relationship. Nature methods. 2005 May;2(5):333-6. 
20. Svendsen CN, ter Borg MG, Armstrong RJ, Rosser AE, Chandran S, 
Ostenfeld T, et al. A new method for the rapid and long term growth of human neural 
precursor cells. Journal of neuroscience methods. 1998 Dec 1;85(2):141-52. 
21. Conti L, Pollard SM, Gorba T, Reitano E, Toselli M, Biella G, et al. Niche-
independent symmetrical self-renewal of a mammalian tissue stem cell. PLoS 
biology. 2005 Sep;3(9):e283. 
22. Zhang SC, Wernig M, Duncan ID, Brustle O, Thomson JA. In vitro 
differentiation of transplantable neural precursors from human embryonic stem cells. 
Nature biotechnology. 2001 Dec;19(12):1129-33. 
23. Corti S, Nizzardo M, Nardini M, Donadoni C, Locatelli F, Papadimitriou D, et 
al. Isolation and characterization of murine neural stem/progenitor cells based on 
Prominin-1 expression. Experimental neurology. 2007 Jun;205(2):547-62. 
24. Klassen H, Schwartz MR, Bailey AH, Young MJ. Surface markers expressed 
by multipotent human and mouse neural progenitor cells include tetraspanins and 
non-protein epitopes. Neuroscience letters. 2001 Oct 26;312(3):180-2. 
25. Galli R, Pagano SF, Gritti A, Vescovi AL. Regulation of neuronal 
differentiation in human CNS stem cell progeny by leukemia inhibitory factor. 
Developmental neuroscience. 2000;22(1-2):86-95. 
26. Ostenfeld T, Joly E, Tai YT, Peters A, Caldwell M, Jauniaux E, et al. Regional 
specification of rodent and human neurospheres. Brain research Developmental 
brain research. 2002 Mar 31;134(1-2):43-55. 
27. Ostenfeld T, Caldwell MA, Prowse KR, Linskens MH, Jauniaux E, Svendsen 
CN. Human neural precursor cells express low levels of telomerase in vitro and show 
diminishing cell proliferation with extensive axonal outgrowth following 
transplantation. Experimental neurology. 2000 Jul;164(1):215-26. 
28. Culbreth ME, Harrill JA, Freudenrich TM, Mundy WR, Shafer TJ. Comparison 
of chemical-induced changes in proliferation and apoptosis in human and mouse 
neuroprogenitor cells. Neurotoxicology. 2012 Dec;33(6):1499-510. 
29. Harrill JA, Freudenrich TM, Robinette BL, Mundy WR. Comparative sensitivity 
of human and rat neural cultures to chemical-induced inhibition of neurite outgrowth. 
Toxicology and applied pharmacology. 2011 Nov 1;256(3):268-80. 
30. Gage FH, Coates PW, Palmer TD, Kuhn HG, Fisher LJ, Suhonen JO, et al. 
Survival and differentiation of adult neuronal progenitor cells transplanted to the adult 
brain. Proceedings of the National Academy of Sciences of the United States of 
America. 1995 Dec 5;92(25):11879-83. 
31. Svendsen CN, Caldwell MA, Shen J, ter Borg MG, Rosser AE, Tyers P, et al. 
Long-term survival of human central nervous system progenitor cells transplanted 
into a rat model of Parkinson's disease. Experimental neurology. 1997 
Nov;148(1):135-46. 
32. Kallur T, Darsalia V, Lindvall O, Kokaia Z. Human fetal cortical and striatal 
neural stem cells generate region-specific neurons in vitro and differentiate 
extensively to neurons after intrastriatal transplantation in neonatal rats. Journal of 
neuroscience research. 2006 Dec;84(8):1630-44. 
33. Lee HJ, Lim IJ, Lee MC, Kim SU. Human neural stem cells genetically 
modified to overexpress brain-derived neurotrophic factor promote functional 
recovery and neuroprotection in a mouse stroke model. Journal of neuroscience 
research. 2010 Nov 15;88(15):3282-94. 
34. Delcroix GJ, Schiller PC, Benoit JP, Montero-Menei CN. Adult cell therapy for 
brain neuronal damages and the role of tissue engineering. Biomaterials. 2010 
Mar;31(8):2105-20. 
35. Gage FH, Temple S. Neural stem cells: generating and regenerating the 
brain. Neuron. 2013 Oct 30;80(3):588-601. 
 
 
Table legends 
 
 
Table 1. The process of neurogenesis in rodents and humans can be distinguished 
by clear physiological and structural differences.  
 
Table 2. A summary of the markers currently used for the characterisation of rodent 
and human neural stem cells. These markers include markers of “stemness” or 
multilineage potential as well as proliferation and the three major neural lineages.  
 
 
 
Figure legends 
 
Figure 1. A timeline illustrating advances in rodent and human adult 
neurogenesis and neural stem cell research. Rodent model systems (rat and 
mouse) have provided significant advances in adult neurogenesis research as well 
as in the identification, isolation and propagation of NSCs enabling the identification 
and use of human NSC models. The timeline demonstrates and compares the 
advances between rodent and human adult neurogenesis research along with the 
development of models of NSC isolation and expansion.  
 
 
Figure 2. A schematic representation of similarities and differences between 
rodent and human neural stem cell in vitro models. A) The expansion of rodent 
and human NSCs share similarities with both rodent and human NSCs isolated from 
fetal and adult tissue and expanded in culture as neurospheres or as an adherent 
monolayer in the presence of growth factors EGF and FGF-2. Upon withdrawal of 
growth factors rodent and human NSCs can be induced to differentiate toward 
neurons, astrocytes or oligodendrocytes. B) A summary of previous direct 
comparative studies of rodent and human NSCs that have identified distinct 
differences between these in vitro models. Differences observed include 
characterisation markers, cell growth, lineage differentiation, cytokine and growth 
factor signalling, telomere length, telomerase expression and sensitivity to 
exogenous factors. 
 
Location       Differences Ref. 
   
   
   
Hippocampus  Neuron turnover higher in humans than rodents Spalding et al. [14] 
  Relative age-related decrease of neurogenesis higher 
in rodents than humans 
Spalding et al. [14] 
   
SVZ  Presence of astrocyte ribbon in humans Sanai et al. [10] 
  No chain migration in human RMS Wang et al. [12] 
  No neuroblasts detected in human OB Wang et al. [12] 
   
   
 
 
Neural Stem Cell Proliferation Neuronal Astrocyte Oligodendrocyte 
     
CD133 (Prominin-1) BrdU Dcx GFAP GalC 
Nestin Ki67 MAP2 S100B O4 
Sox1 Mcm2 NeuN   
Sox2 PCNA Neurofilament   
Musashi 1  NSE   
Vimentin  PSA-NCAM   
  TuJ1 (III-tubulin)   
     
Ref. [13,18,21,23] [5,11-13] [5,8,10,13,18,21]  [5,8,10,18,21] [10,18,26] 
 
 
